Author

L. Maroc

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:fungi (other)· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

R. S. Shapiro· 2 shared A. K. Dube· 1 shared A. Pageau· 1 shared C. Bedard· 1 shared C. R. Landry· 1 shared H. Shaker· 1 shared I. Gagnon-Arsenault· 1 shared J. Boisvert· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

R. S. Shapiro

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Most azole antifungal resistance mutations in the drug target provide cross-resistance and carry no intrinsic fitness cost

C. Bedard, I. Gagnon-Arsenault, J. Boisvert, S. Plante, A. K. Dube, A. Pageau, J. Sharma, L. Maroc, R. S. Shapiro, C. R. Landry

The paper evaluates 4,000 Erg11 variants to determine azole resistance and fitness costs, finding 33% resistance, 88% cross-resistance, and minimal fitness cost.

bioRxiv · Dec 13, 2023 · PreprintMicrobiology

Functional genetic characterization of stress tolerance and biofilm formation in Nakaseomyces glabrata via a novel CRISPR activation system

L. Maroc, H. Shaker, R. S. Shapiro

This paper develops and validates a CRISPR activation system in Nakaseomyces glabrata to study gene overexpression in pathogenesis and drug resistance.

bioRxiv · Dec 7, 2023 · PreprintMicrobiology